Raymond James & Associates’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,456	Closed	-$515K	–	3962
2024 Q1	$515K	Buy	+7,456	New	+$450K	﹤0.01%	3050
2020 Q1	–	Sell	-3,930	Closed	-$242K	–	3502
2019 Q4	$242K	Sell	3,930 -833	-17%	-$55.2K	﹤0.01%	3226
2019 Q3	$347K	Sell	4,763 -124	-3%	-$9.28K	﹤0.01%	2920
2019 Q2	$402K	Sell	4,887 -425	-8%	-$30.2K	﹤0.01%	2822
2019 Q1	$375K	Sell	5,312 -9,591	-64%	-$564K	﹤0.01%	2852
2018 Q4	$671K	Buy	14,903 +2,998	+25%	+$157K	﹤0.01%	2339
2018 Q3	$673K	Buy	11,905 +1,450	+14%	+$88.7K	﹤0.01%	2497
2018 Q2	$698K	Sell	10,455 -3,965	-27%	-$248K	﹤0.01%	2448
2018 Q1	$840K	Sell	14,420 -7,042	-33%	-$447K	﹤0.01%	2259
2017 Q4	$1.38M	Sell	21,462 -1,528	-7%	-$95.1K	﹤0.01%	1934
2017 Q3	$1.21M	Buy	22,990 +17,976	+359%	+$857K	﹤0.01%	1984
2017 Q2	$235K	Sell	5,014 -354	-7%	-$17.1K	﹤0.01%	2886
2017 Q1	$266K	Buy	5,368 +92	+2%	+$5.17K	﹤0.01%	2767
2016 Q4	$320K	Buy	5,276 +280	+6%	+$17.1K	﹤0.01%	2591
2016 Q3	$331K	Buy	+4,996	New	+$312K	﹤0.01%	2554